Second Circuit Nixes Whistleblower Action Against MedImmune Under Public Disclosure Bar
- March 20, 2020
The Second Circuit affirmed March 18 the dismissal of a False Claims Act (FCA) qui tam action against MedImmune Inc. after finding the whistleblower wasn’t the original source of publicly disclosed kickback allegations.
ARTICLE TAGS
You must be logged in to access this content.